• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-羟色胺2A受体拮抗剂可增加2型糖尿病患者体内的脂联素水平。

5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes.

作者信息

Nomura Shosaku, Shouzu Akira, Omoto Seitarou, Nishikawa Mitsushige, Iwasaka Toshiji

机构信息

First Department of Internal Medicine, Kansai Medical University, Moriguchi, Osaka, Japan.

出版信息

Blood Coagul Fibrinolysis. 2005 Sep;16(6):423-8. doi: 10.1097/01.mbc.0000176197.48134.08.

DOI:10.1097/01.mbc.0000176197.48134.08
PMID:16093733
Abstract

We compared the levels of plasma adiponectin, platelet activation markers (P-selectin, CD63, PAC-1, annexin V, and platelet-derived microparticles), and endothelial injury markers (soluble E-selectin and soluble vascular cell adhesion molecule-1) in 53 patients with type 2 diabetes mellitus to investigate potential contributions to diabetic vascular complications. In addition, we administered serotonin antagonist (sarpogrelate hydrochloride) to type 2 diabetes patients who had increased soluble E-selectin levels. The concentrations of platelet activation markers and endothelial injury markers in diabetic patients were significantly higher than those in normal subjects. However, levels of adiponectin were lower in type 2 diabetes patients than in control subjects. A total of 32 patients had high-soluble E-selectin levels (soluble E-selectin >or= 62 ng/ml); a subset of patients that also had significant elevation of platelet activation and endothelial injury markers compared with patients without high soluble E-selectin. In addition, both platelet-P-selectin and platelet-derived microparticle levels negatively correlated with the adiponectin level. Patients with high soluble E-selectin exhibited significant improvement of all markers after sarpogrelate hydrochloride treatment. These findings suggest that there is a link between vascular change in type 2 diabetes and activated platelets, endothelial dysfunction, and an adiponectin abnormality.

摘要

我们比较了53例2型糖尿病患者的血浆脂联素水平、血小板活化标志物(P-选择素、CD63、PAC-1、膜联蛋白V和血小板衍生微粒)以及内皮损伤标志物(可溶性E-选择素和可溶性血管细胞黏附分子-1),以研究它们对糖尿病血管并发症的潜在影响。此外,我们对可溶性E-选择素水平升高的2型糖尿病患者给予了5-羟色胺拮抗剂(盐酸沙格雷酯)。糖尿病患者的血小板活化标志物和内皮损伤标志物浓度显著高于正常受试者。然而,2型糖尿病患者的脂联素水平低于对照组。共有32例患者可溶性E-选择素水平较高(可溶性E-选择素≥62 ng/ml);与可溶性E-选择素水平不高的患者相比,这部分患者的血小板活化和内皮损伤标志物也显著升高。此外,血小板P-选择素和血小板衍生微粒水平均与脂联素水平呈负相关。盐酸沙格雷酯治疗后,可溶性E-选择素水平较高的患者所有标志物均有显著改善。这些发现表明,2型糖尿病的血管变化与活化血小板、内皮功能障碍和脂联素异常之间存在联系。

相似文献

1
5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes.5-羟色胺2A受体拮抗剂可增加2型糖尿病患者体内的脂联素水平。
Blood Coagul Fibrinolysis. 2005 Sep;16(6):423-8. doi: 10.1097/01.mbc.0000176197.48134.08.
2
Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.阻断5-羟色胺2A受体可改善链脲佐菌素诱导的糖尿病肾病大鼠的肾小球内皮功能。
Clin Exp Nephrol. 2008 Apr;12(2):119-125. doi: 10.1007/s10157-007-0011-8. Epub 2008 Jan 5.
3
Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes.活化血小板和氧化型低密度脂蛋白诱导内皮细胞膜囊泡化:2型糖尿病患者内皮细胞衍生微粒的临床意义
Clin Appl Thromb Hemost. 2004 Jul;10(3):205-15. doi: 10.1177/107602960401000302.
4
Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans.盐酸沙格雷酯对闭塞性动脉硬化症患者二磷酸腺苷或胶原诱导的血小板反应的影响
Blood Coagul Fibrinolysis. 2001 Jul;12(5):391-7. doi: 10.1097/00001721-200107000-00009.
5
Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).沙格雷酯、二十碳五烯酸和匹伐他汀对2型糖尿病患者闭塞性动脉硬化相关生物标志物的影响(SAREPITASO研究)
Vasc Health Risk Manag. 2018 Sep 18;14:225-232. doi: 10.2147/VHRM.S171143. eCollection 2018.
6
Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus.二十碳五烯酸对2型糖尿病高脂血症患者血小板活化标志物和细胞黏附分子的影响。
J Diabetes Complications. 2003 May-Jun;17(3):153-9. doi: 10.1016/s1056-8727(02)00172-1.
7
Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients.阿卡波糖对糖尿病患者血小板衍生的微颗粒、可溶性选择素和脂联素的影响。
J Thromb Thrombolysis. 2009 Nov;28(4):429-35. doi: 10.1007/s11239-008-0301-3. Epub 2009 Jan 10.
8
Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus.依福地平对伴或不伴2型糖尿病的高血压患者血小板及单核细胞活化标志物的影响。
J Hum Hypertens. 2002 Aug;16(8):539-47. doi: 10.1038/sj.jhh.1001447.
9
Sarpogrelate hydrochloride decreases cardio-ankle vascular index accompanied by increased serum lipoprotein lipase mass in type 2 diabetic patients.盐酸沙格雷酯可降低2型糖尿病患者的心脏-踝部血管指数,同时血清脂蛋白脂肪酶质量增加。
Int Heart J. 2014;55(4):337-41. doi: 10.1536/ihj.13-377. Epub 2014 Jun 5.
10
Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.2型糖尿病患者中单核细胞衍生微粒的检测
Diabetologia. 2002 Apr;45(4):550-5. doi: 10.1007/s00125-001-0772-7.

引用本文的文献

1
Improvement of Cardiac Function and Subcellular Defects Due to Chronic Diabetes upon Treatment with Sarpogrelate.使用沙格雷酯治疗对慢性糖尿病所致心脏功能及亚细胞缺陷的改善作用。
J Cardiovasc Dev Dis. 2024 Jul 9;11(7):215. doi: 10.3390/jcdd11070215.
2
Influences of Serotonin Hydrochloride on , and Genes Expression.盐酸血清素对、和基因表达的影响。 (注:原文中“、”之间内容缺失,此为按现有内容翻译)
Galen Med J. 2020 Sep 7;9:e1767. doi: 10.31661/gmj.v9i0.1767. eCollection 2020.
3
Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran.
达比加群治疗的心房颤动患者内皮细胞和血小板微粒的流式细胞术评估
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620972467. doi: 10.1177/1076029620972467.
4
Microparticles and cardiovascular diseases.微粒与心血管疾病。
Ann Med. 2019 May-Jun;51(3-4):193-223. doi: 10.1080/07853890.2019.1609076. Epub 2019 Jun 17.
5
Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).沙格雷酯、二十碳五烯酸和匹伐他汀对2型糖尿病患者闭塞性动脉硬化相关生物标志物的影响(SAREPITASO研究)
Vasc Health Risk Manag. 2018 Sep 18;14:225-232. doi: 10.2147/VHRM.S171143. eCollection 2018.
6
Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.盐酸沙格雷酯可改善db/db小鼠的糖尿病肾病,其与抑制巨噬细胞活性和炎症反应有关。
PLoS One. 2017 Jun 22;12(6):e0179221. doi: 10.1371/journal.pone.0179221. eCollection 2017.
7
Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity.血清素作为糖尿病和肥胖症的新治疗靶点
Diabetes Metab J. 2016 Apr;40(2):89-98. doi: 10.4093/dmj.2016.40.2.89.
8
Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro.血清素拮抗剂对体内和体外白细胞与内皮细胞相互作用的抑制作用。
PLoS One. 2016 Jan 29;11(1):e0147929. doi: 10.1371/journal.pone.0147929. eCollection 2016.
9
Peripheral Serotonin: a New Player in Systemic Energy Homeostasis.外周血清素:全身能量稳态中的新角色。
Mol Cells. 2015 Dec;38(12):1023-8. doi: 10.14348/molcells.2015.0258. Epub 2015 Dec 1.
10
Skeletal integration of energy homeostasis: Translational implications.能量稳态的骨骼整合:转化意义。
Bone. 2016 Jan;82:35-41. doi: 10.1016/j.bone.2015.07.026. Epub 2015 Jul 23.